Core and Group Health

Only 12% of employers are focused on improving pharmacy benefits.

U.S. prescription drug spending is projected to nearly double, reaching more than $1 trillion by 2030. In response, many employers are turning to independent, next-generation PBMs.

One section could put HHS Secretary Robert F. Kennedy Jr. in charge of making sure PBMs send employer plan sponsors detailed reports.

The new arrangement could cut patients' copays to $25 per month, or less, for Wegovy, Zepbound, Ozempic and Rybelsus

In this episode, we sit down with Tracy Watts, senior partner, national leader for U.S. Health Care Policy at Mercer. The wide-ranging discussion includes her thoughts on all the noise coming out of Washington D.C. right now to a few of the innovative benefits design strategies and ideas she’s watching most closely right now.

For now, however, they're trying to implement what's already here, like letting workers use up to $150 in HSA cash per month to pay for direct primary care fees.